Stay updated with breaking news from Biological E. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Read more about Govt to reserve 300 mn doses of Biological-E vaccine for August-December on Business Standard. The formulation, an RBD protein sub-unit vaccine, is currently undergoing Phase-3 trials
For this purpose, the Ministry of Health would be making an advance payment of ₹1,500 crore. The vaccine of Biological-E was currently undergoing Phase-3 clinical trial after it showed promising results in Phase 1 and 2 clinical trials. The RBD protein sub-unit vaccine is likely to be available in the next few months. “The proposal of M/s Biological-E was examined and recommended for approval after due diligence by National Expert Group on Vaccine Administration for COVID-19 (NEGVAC),” the Ministry said. It added that the arrangement with the manufacturer is part of the wider endeavour ...
The vaccine, which is currently undergoing phase-3 clinical trials, is likely to be available in the next few months, the health ministry said in a statement.
The RBD protein sub-unit vaccine, which is currently undergoing phase-3 clinical trials, is likely to be available in the next few months, the health ministry said in a statement.
Synopsis So far, only about 4.7% of the 950 million adult population have been given two vaccine doses as the world's second-most populous country reels from a devastating second wave of infections that killed around 170,000 people in April and May alone. Reuters India signed its first order for an unapproved COVID-19 vaccine on Thursday, a day after it faced criticism from the Supreme Court over its bungled vaccine rollout that has left millions of people vulnerable after almost 338,000 deaths. So far, only about 4.7% of the 950 million adult population have been given two vaccine doses as t...